|
市場調査レポート
商品コード
1768081
膵臓がん治療薬・診断薬市場：タイプ別、地域別Pancreatic Cancer Therapeutics and Diagnostic Market, By Type (Treatment (Targeted Therapies, Chemotherapy, Surgery, and Other Treatments)), By Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) |
||||||
カスタマイズ可能
|
|||||||
| 膵臓がん治療薬・診断薬市場：タイプ別、地域別 |
|
出版日: 2025年06月09日
発行: Coherent Market Insights
ページ情報: 英文 170 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
膵臓がん治療薬・診断薬市場は、2025年には36億8,960万米ドルと推定され、2032年には60億3,930万米ドルに達すると予測され、2025～2032年までの年間平均成長率（CAGR）は7.3%で成長する見込みです。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024年 | 2025年の市場規模 | 36億8,960万米ドル |
| 実績データ | 2020～2024年 | 予測期間 | 2025～2032年 |
| 予測期間：2025～2032年 | 7.30% | 2032年の金額予測 | 60億3,930万米ドル |
膵臓がんは、膵臓の細胞にできるがんです。膵臓がんは、膵臓細胞の変化（突然変異）によって制御不能に増殖することで発生します。がんは、超音波検査、コンピューター断層撮影（CT）検査、磁気共鳴画像法（MRI）検査、陽電子放射断層撮影（PET）検査などで診断することができます。治療には、手術、放射線療法、化学療法、またはこれらの組み合わせが含まれます。
市場力学
膵臓がんの罹患率と有病率の上昇、新規治療の開発の増加、高齢者の増加、安全で効果的な治療に対する需要の増加、人々の意識の高まりは、世界の膵臓がん治療・診断市場の成長を増大させると予想される主要因です。
例えば、2021年1月、Myriad Genetics Inc.とIllumina Inc.は、膵臓がんの検出に使用できるmyChoiceコンパニオン診断検査のキットベース版を国際市場向けに共同開発しました。
さらに、2020年9月、インド医療研究評議会（ICMR）-国立がん予防研究センター（NICPR）は、「India against Cancer」をテーマに、膵臓がんを含むがんの啓発、予防、治療に主眼を置き、インドの主要ながんに関する情報を提供するポータルサイトwww.cancerindia.org。
本調査の主要特徴
- 本レポートでは、世界の膵臓がん治療薬・診断薬市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模と複合年間成長率（CAGR）を掲載しています。
- さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。
- また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
- 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などの以下のパラメータに基づいて、世界の膵臓がん治療薬・診断薬市場の主要企業プロファイルを掲載しています。
- このレポートから洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
- この調査レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者を対象としています。
- 利害関係者は、世界の膵臓がん治療薬・診断薬市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
- 一貫型機会マップ（COM）
第3章 市場力学、規制、動向分析
- 市場力学
- 膵臓がんの発生率と有病率の上昇
- 診断と治療にかかる高額な費用
- 安全で効果的な治療の需要の増加
- 影響分析
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- ポーター分析
- 合併と買収のシナリオ
第4章 膵臓がん治療薬・診断薬の世界市場、タイプ別、2020～2032年
- イントロダクション
- 治療薬
- 診断薬
第5章 膵臓がん治療薬・診断薬の世界市場、地域、2020～2032年
- イントロダクション
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東
- アフリカ
第6章 競合情勢
- F. Hoffmann-La Roche AG
- Merck KgaA
- Apexigen Inc.
- Immunovia AB
- Viatris Inc.
- Amgen Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb
- Novartis AG
- Pfizer Inc.
- Myriad Genetics Inc.
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Boston Scientific Corporation
- Rafael Holdings Inc.（Rafael Pharmaceuticals）
第7章 セクション
- 調査手法
- 出版社について
Pancreatic Cancer Therapeutics And Diagnostic Market is estimated to be valued at USD 3,689.6 Mn in 2025 and is expected to reach USD 6,039.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3,689.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.30% | 2032 Value Projection: | USD 6,039.3 Mn |
Pancreatic cancer is cancer that forms in the cells of the pancreas. Pancreatic cancer occurs when changes (mutations) in the pancreas cells lead them to multiply out of control. The cancer can be diagnosed with the help of ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Treatment may include surgery, radiation, chemotherapy, or a combination of these.
Market Dynamics:
Rise in incidence and prevalence of pancreatic cancer, rise in development of novel therapeutics, growing geriatric population, increase in demand for safe and effective therapeutics, and increase in awareness among people are major factors expected to augment growth of the global pancreatic cancer therapeutics and diagnostic market.
For instance, in January 2021, Myriad Genetics Inc. and Illumina Inc. collaborated to develop a kit-based version of the myChoice companion diagnostic test for international markets, which can be used to detect pancreatic cancer.
Moreover, in September 2020, the Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR) launched www.cancerindia.org with the theme 'India against Cancer, a portal that provides information on the leading cancers in India with the major focus on awareness, prevention, and treatment of cancers, including pancreatic cancer.
Key features of the study:
- This report provides in-depth analysis of the global pancreatic cancer therapeutics and diagnostic market, and provides market size (USD Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global pancreatic cancer therapeutics and diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include F Hoffmann-La Roche AG, Merck KgaA, Apexigen Inc., Immunovia AB, Viatris Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb, Novartis AG, Pfizer Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, and Rafael Holdings Inc. (Rafael Pharmaceuticals), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global pancreatic cancer therapeutics and diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pancreatic cancer therapeutics and diagnostic market.
Detailed Segmentation:
- Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type:
- Treatment
- Diagnostics
- Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography:
- North America
- Europe
- Asia Pacific
- Middle East
- Africa
- Latin America
- Company Profiles:
- F.Hoffmann-La Roche AG
- Merck KgaA
- Apexigen Inc.
- Immunovia AB
- Viatris Inc.
- Amgen Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb
- Novartis AG
- Pfizer Inc.
- Myriad Genetics Inc.
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Boston Scientific Corporation
- Rafael Holdings Inc. (Rafael Pharmaceuticals)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in incidence and prevalence of pancreatic cancer
- High cost associated with diagnosis and treatments
- Increase in demand for safe and effective therapeutics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
5. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
- GCC Country
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
- South Africa
- North Africa
- Central Africa
6. Competitive Landscape
- F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Apexigen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Immunovia AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Myriad Genetics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FUJIFILM Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rafael Holdings Inc. (Rafael Pharmaceuticals)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
7. Section
- Research Methodology
- About us
